Status:
COMPLETED
Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
16-99 years
Brief Summary
.During one year all the resected basal cell carcinomas (BCC) analyzed in Montpellier University Hospital Anatomopathology unit were included in this study. Localisation and histological characteristi...
Eligibility Criteria
Inclusion
- Cohort :
- Inclusion criteria:
- \- Patients with resected BCC
- Exclusion criteria:
- Biopsies of BCC,
- revised surgery of incomplete resection.
- Cases :
- Inclusion criteria:
- Recurrent BCC with complete first resection
- Exclusion criteria:
- \- Recurrent BCC with incomplete first resection, Patients with Gorlin syndrome (a genetic disease that increase risk of BCC)
Exclusion
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2021
Estimated Enrollment :
804 Patients enrolled
Trial Details
Trial ID
NCT04795297
Start Date
February 1 2020
End Date
February 20 2021
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295